Delivery Order SPE2DB22D1202-SPE2DB24FVMT6
Award Date
9/5/24
Potential Completion Date
9/6/24
Potential Value
$7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,387.14 firm fixed-price delivery order is for 4,567,105,161 units of the medication Ondansetron ODT 4 mg Tablet 30s, with a performance period through January 31, 2025. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
The Defense Logistics Agency (DLA) awarded a $1,029.66 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,749,615 units of the drug Ondansetron HCl 4 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,721.55 firm fixed-price delivery order is for the supply of 4,568,188,809 units of the prescription medication Ondansetron HCL 4 MG Tablet, with a completion date of May 9, 2025. The contract is not set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $11,566.08 for the supply of 4,565,520,865 units of the medication ondansetron hydrochloride 4 mg tablets. The contract is a firm fixed price agreement with the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract has an ultimate completion date of August 21, 2024 and was awarded on August 20, 2024. This delivery order is likely part of a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,264.96 firm fixed-price delivery order is for the supply of 4 mg Ondansetron HCL tablets. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award, valued at $16,658.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of 4,565,600 units of the prescription drug Ondansetron HCL 4mg Tablet. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical for supplying a wide range of pharmaceutical and medical supplies to support military treatment programs...
This federal contract award, valued at $1,228.91, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB22D2006|SPE2DB25FW0LP) for the supply of 4,568,092 units of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of May 1, 2025 and is a firm fixed-price arrangement. This award is not associated with a set-aside program and is part of a...
This federal contract award, worth $1,440.94, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,565,689,323 units of Ondansetron ODT 4 mg tablets in 30-count packs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to...
This is a $1,952.62 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,909,307 units of Ondansetron HCL 4 mg tablets. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,671.40 firm-fixed-price delivery order is for the supply of 4,568,158,714 units of the medication Ondansetron ODT 4 mg tablet, with a performance period ending on May 7, 2025. The award is not associated with a set-aside program and appears to be part of a larger Indefinite Delivery Contract (IDC) valued at...